JASON BRYANT: Open Payments
NPI 1124470935 · COSHOCTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$456 in 25 payments from 14 companies in 2025. Trend: 2023 $296 · 2024 $422 · 2025 $456
Food & beverage: $456
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $74 |
| Novartis Pharmaceuticals Corporation | 3 | $53 |
| ABBVIE INC. | 3 | $52 |
| PFIZER INC. | 2 | $40 |
| Merck Sharp & Dohme LLC | 2 | $39 |
| Novo Nordisk Inc | 2 | $33 |
| Esperion Therapeutics, Inc. | 2 | $31 |
| Kestra Medical Technology Services, Inc. | 1 | $29 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
Products named: REPATHA, LEQVIO, VYNDAQEL, VERQUVO, CREON, Wegovy, NEXLETOL, Assure WCD.
Industry payments across OH — which companies pay providers there.
